From New York Times
F.D.A. Rejects Closely Watched Lung Cancer Drug From China
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
From New York Times
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.